
FDA authorizes third Johnson & Johnson COVID-19 vaccine batch from troubled Baltimore plant
Fox News
The Food and Drug Administration on Tuesday announced that it had authorized an additional batch of Johnson & Johnson COVID-19 vaccine that had been produced from a troubled Baltimore facility.
The company has been told previously to discard doses from the plant, which has been repeatedly cited for problems pertaining to poorly trained employees, cracked vials and mold issues, according to the Associated Press.More Related News













